Oncology Publications

Seagrove Partners’ Extensive Library of Market Reports and Tumor Primers

 

Seagrove Partners, a boutique healthcare market research company based in San Diego, has created an extensive library of oncology research reports that serve as detailed market primers for industry professionals, clinical researchers and students. The research is anchored by the annual Oncology and Hematology Blue Books which provides an overview of the commercial landscape, clinical outcomes, company pipelines, and product messaging for 13 different tumor types (oncology and hematology). Following the Blue Books are extensive deep dives into areas like Breast Cancer, Lymphoma, Lung Cancer, Multiple Myeloma, Gastric Cancer and Pancreatic Cancer. Reports are available for purchase via individual license or through our entity-wide syndicated membership offering.

The 2024 Oncology Blue Book. Your One-Stop for Market Data, Facts, Figures and Insights.

Published annually after ASCO, the Oncology Blue Book provides detailed overviews of the following tumor types: Bladder Cancer, Breast Cancer, CRC, Liver Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, and Renal Cancer. 310+ Pages.

PURCHASE

The 2024 Hematology Blue Book. Your One-Stop for Market Data, Facts, Figures and Insights.

Published annually after ASCO, the Hematology Blue Book provides detailed overviews of the following tumor types: Leukemia, Lymphoma, and Multiple Myeloma. 200+ Pages.

PURCHASE

The 2024-25 Early Cancer Detection Market Primer.

Published in early 2025, this report provides a deep-dive into the exciting fields of genomics and proteomics and how early cancer detection is reshaping cancer therapeutics in terms of clinical development, medical practice and outcomes from peri-and adjuvant therapies. Companies covered include Exact Sciences, Grail, Guardant, and Natera, among others. Content includes market statistics, clinical definitions, company overviews, pipelines, technology deep-dive and clinical applications.

PURCHASE

The Oncology Forum:


SeaTRAK™ Quarterly Monitor

Seagrove’s quarterly market tracker published after earnings season. Includes updates to market statistics, company earnings coverage and analysis, and pipeline updates.

Other Oncology Publications

  • New Targets Series: Hematology

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics.
    166 pages.

    PURCHASE

  • New Targets Series: Gastric Cancer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics.
    137 pages.

    PURCHASE

  • New Targets Series: Breast Cancer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics.
    125 pages.

    PURCHASE

  • New Targets Series: Lung Cancer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics.
    213 pages.

    PURCHASE

  • Colorectal Cancer Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics.
    118 pages.

    PURCHASE

  • Prostate Cancer Market Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.
    91 pages.

    PURCHASE

  • Ovarian Cancer Market Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.
    76 pages.

    PURCHASE

  • Multiple Myeloma Market Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.
    157 pages.

    PURCHASE

  • Lymphoma Market Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.
    167 pages.

    PURCHASSE
PURCHASE

  • Pancreatic Cancer Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.

    95 pages.

  • Checkpoint Inhibitors Primer

    Market statistics, CPI History and Science, Top 10 Oncology: Overview and I-O Pipelines, Biopharma: CPI Players, Outcomes Data.

    181 pages.

  • CAR T Market Primer

    Market statistics, history of CAR T, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.

    99 pages.

  • ASH Conference Coverage

  • SITC Conference Coverage

  • ESMO Conference Coverage

  • 2021 Payer Perspectives

    Managed Care Market Primer, Coverage Processes, Cost Containment Programs, Formulary Tracker Questions, Reactions to New Therapies. 71 pages. 50 Plans.

  • 2021 Oncology Nurses Survey

    Practice Profiles, Industry Statistics, General Trends in Oncology Management, Breast Cancer, Hematology, General (Non-Tumor Specific). 78 pages. 230 Responses.

  • 2021 Oncology HCP Survey

    Practice Profiles, Industry Statistics, General Trends in Oncology Management, Breast Cancer, Hematology, General (Non-Tumor Specific) Ad-Hoc Tumor Questions 96 pages. 146 Responses.